GEHC GE HealthCare

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business: global healthcare solutions provider delivering advanced medical tech, diagnostics, AI, cloud, and software for personalized patient care
• • New emphasis on AI-enabled software solutions upgradeable through equipment lifecycle, enhancing multi-site healthcare network operations
• • Strategic shift post-January 2023 spin-off from General Electric, operating independently with focus on lean system Heartbeat and operational culture
• • Workforce approx. 54,000 employees, with 9,700 sales and 8,900 engineers and field service professionals globally
• • Noteworthy: operates 44 manufacturing/production facilities across 17 countries with global integrated supply chain ensuring resilience and regional compliance

Risk Factors

• • US tariffs on global imports in 2025 materially reduced profitability and cash flows, with ongoing risk of additional tariffs impacting financial results
• • Russia-Ukraine conflict and resulting US, EU sanctions increased costs and restricted supply to Russian customers, with uncertain license approvals from US authorities
• • Supply chain disruptions and raw material shortages causing manufacturing delays, higher costs, and delivery impairments
• • U.S. Librarian of Congress copyright exemption enabling third-party ISOs to access OEM repair software threatens service contracts and revenues
• • Existing indebtedness and potential additional borrowings pose financial constraints and risks to business operations

Management Discussion & Analysis

• • Revenue $20,625M, up 4.8% YoY; Product sales $13,661M (+4.5%, +$586M), Services $6,964M (+5.6%, +$368M)
• • Operating income $2,763M (13.4% margin vs 13.3%), net income $2,084M (10.1% margin, flat YoY)
• • Best segment: PDx revenues $2,900M (+15.6%, +$392M) with EBIT $872M (+11.4%); Worst segment: PCS revenues $3,086M (-1.2%, -$38M) with EBIT $209M (-39.6%)
• • Cost inflation including tariffs increased product costs $671M; operating expenses down $95M due to lower R&D and SG&A; tariffs impacted Operating income by $245M and cash flows by $285M
• • No explicit forward guidance; key risks: ongoing tariffs, geopolitical instability, China market pressures, and trade restrictions may materially impact future results

What are the latest GEHC SEC filings in 2026?

GE HealthCare (GEHC) has filed a 10-K annual report on February 4, 2026, a 10-Q quarterly report on April 29, 2026, an 8-K current report on July 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did GEHC file its most recent 10-K annual report?

GE HealthCare (GEHC) filed its most recent 10-K annual report on February 4, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view GEHC 10-Q quarterly reports?

GE HealthCare (GEHC)'s most recent 10-Q quarterly report was filed on April 29, 2026. SignalX displays every GEHC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has GEHC filed recently?

GE HealthCare (GEHC)'s most recent 8-K was filed on July 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find GEHC insider trading activity (Form 4)?

SignalX aggregates every GEHC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does GEHC file with the SEC?

GE HealthCare (GEHC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new GEHC filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for GE HealthCare (GEHC).

What is GEHC's SEC CIK number?

GE HealthCare (GEHC)'s SEC CIK (Central Index Key) number is 1932393. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1932393 to look up all GEHC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find GEHC return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from GE HealthCare (GEHC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.